author-photo

Maria-Theresa Krauth

Medical University of Vienna

131

Papers

3444

Citations

Citation Trend

Filter By

Papers (95) Sort By

Journal Conference Others

Impact of HFE gene variants on iron overload, overall survival and leukemia-free survival in myelodysplastic syndromes.

2021 American Journal of Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Pathway-Directed Therapy in Multiple Myeloma

2021 Cancers
Show All
- Source
- Cite
- Save
Citations (2)
Composition of the Immune Environment at Baseline Correlates with Time to Response and Treatment Outcome in Newly Diagnosed Transplant-Ineligible Multiple Myeloma (MM) Patients Randomized to Krd or Ktd Followed By Carfilzomib Maintenance or Observation (AGMT_MM 02 Study)

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Stratification for RRMM and Risk-Adapted Therapy: Sequencing of Therapies in RRMM

2021 Cancers
Show All
- Source
- Cite
- Save
Citations (0)
The Agony of Choice-Where to Place the Wave of BCMA-Targeted Therapies in the Multiple Myeloma Treatment Puzzle in 2022 and Beyond.

2021 Cancers
Show All
- Source
- Cite
- Save
Citations (0)
First-line daratumumab shows high efficacy and tolerability even in advanced AL amyloidosis: the real-world experience.

2021
Show All
- Source
- Cite
- Save
Citations (1)
Short tutorial. Treatment options in light chain amyloidosis and monoclonal gammopathy of renal significance

2021 Memo – Magazine of European Medical Oncology
- Maria-Theresa Krauth
- Hermine Agis
Show All
- Source
- Cite
- Save
Citations (0)
Austrian recommendations for the management of essential thrombocythemia.

2020 Wiener Klinische Wochenschrift
Show All
- Source
- Cite
- Save
Citations (1)
Elotuzumab, pomalidomide, and dexamethasone is a very well tolerated regimen associated with durable remission even in very advanced myeloma: a retrospective study from two academic centers.

2020 Journal of Cancer Research and Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
Immunophenotyping of Baseline Bone Marrow Reveals a Specific Pattern of Immune Cells Associated with Greater Depth and Sustained Response in Newly Diagnosed Patients Randomized to Krd or Ktd Followed By Carfilzomib Maintenance or Control (AGMT MM 02 Study)

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)